Meyer Handelman Company’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Hold |
13,899
| – | – | ﹤0.01% | 215 |
|
|
2025
Q1 | $85.6K | Hold |
13,899
| – | – | ﹤0.01% | 212 |
|
|
2024
Q4 | $70.9K | Hold |
13,899
| – | – | ﹤0.01% | 210 |
|
|
2024
Q3 | $69.9K | Hold |
13,899
| – | – | ﹤0.01% | 212 |
|
|
2024
Q2 | $57.1K | Hold |
13,899
| – | – | ﹤0.01% | 205 |
|
|
2024
Q1 | $106K | Hold |
13,899
| – | – | ﹤0.01% | 201 |
|
|
2023
Q4 | $116K | Hold |
13,899
| – | – | ﹤0.01% | 188 |
|
|
2023
Q3 | $117K | Buy |
13,899
+661
| +5% | +$5.59K | ﹤0.01% | 188 |
|
|
2023
Q2 | $126K | Buy |
+13,238
| New | +$126K | 0.01% | 183 |
|